BPG is committed to discovery and dissemination of knowledge
Clinical Trials Study
©2014 Baishideng Publishing Group Inc.
World J Hepatol. Jul 27, 2014; 6(7): 513-519
Published online Jul 27, 2014. doi: 10.4254/wjh.v6.i7.513
Table 1 Patients’ first assessment demographic and clinical characteristics
PatientsGenderAge (yr)Primary colonic tumour locationMetastatic type (liver-limited)Colonic obstruction > stent placement
1Male67SigmoidII-
2Male75SigmoidII-
3Female37SigmoidIII-
4Male79SigmoidIII√
5Male79DescendingIII√
6Male40SigmoidII√
7Female75SigmoidII-
8Male59DescendingIII-
9Female78DescendingIII√
10Male59SigmoidIII√
11Male75AscendingII-
Table 2 Patients’ operative treatment and oncologic characteristics
PatientsMetastatic type (liver-limited)Hepatectomy 1Hepatectomy 2ColectomyDisease-free
Overall
Survival period (mo)
1IIRE and wedge and RFA-MWA-√8.2339.57
2IIRightLeft lateral and RFA-MWA√2.2014.17
3III----13.97
4III----7.33
5III----13.37
6IILaparoscopic left lateralRight√15.2739.17
7IILeft lateralRight√5.2715.57
8III----9.43
9IIILaparoscopic left lateral---7.80
10III----11.5
11II----10.1


Write to the Help Desk